Literature DB >> 22036596

Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes.

Rebecca L Sanchez1, Alistair J Ramsay, Timothy P Foster.   

Abstract

Generation and isolation of recombinant herpesviruses by traditional homologous recombination methods can be a tedious, time-consuming process. Therefore, a novel stoplight recombination selection method was developed that facilitated rapid identification and purification of recombinant viruses expressing fusions of immunological epitopes with EGFP. This "traffic-light" approach provided a visual indication of the presence and purity of recombinant HSV-1 isolates by producing three identifying signals: (1) red fluorescence indicates non-recombinant viruses that should be avoided; (2) yellow fluorescence indicates cells co-infected with non-recombinant and recombinant viruses that are chosen with caution; (3) green fluorescence indicates pure recombinant isolates and to proceed with preparation of viral stocks. Adaptability of this system was demonstrated by creating three recombinant viruses that expressed model immunological epitopes. Diagnostic PCR established that the fluorescent stoplight indicators were effective at differentiating between the presence of background virus contamination and pure recombinant viruses specifying immunological epitopes. This enabled isolation of pure recombinant viral stocks that exhibited wildtype-like viral replication and cell-to-cell spread following three rounds of plaque purification. Expression of specific immunological epitopes was confirmed by western analysis, and the utility of these viruses for examining host immune responses to HSV-1 was determined by a functional T cell assay.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036596      PMCID: PMC3249488          DOI: 10.1016/j.jviromet.2011.10.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  54 in total

1.  Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication.

Authors:  T P Foster; G V Rybachuk; K G Kousoulas
Journal:  J Virol Methods       Date:  1998-11       Impact factor: 2.014

2.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

3.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.

Authors:  R Tomazin; A B Hill; P Jugovic; I York; P van Endert; H L Ploegh; D W Andrews; D C Johnson
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

4.  An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996.

Authors:  R L Hendricks
Journal:  Cornea       Date:  1997-09       Impact factor: 2.651

5.  Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47.

Authors:  P Jugovic; A M Hill; R Tomazin; H Ploegh; D C Johnson
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Herpes simplex virus glycoprotein K promotes egress of virus particles.

Authors:  L Hutchinson; D C Johnson
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein.

Authors:  T P Foster; V N Chouljenko; K G Kousoulas
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

8.  Pseudorabies virus glycoprotein gK is a virion structural component involved in virus release but is not required for entry.

Authors:  B G Klupp; J Baumeister; P Dietz; H Granzow; T C Mettenleiter
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice.

Authors:  D J Maggs; E Chang; M P Nasisse; W J Mitchell
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth.

Authors:  C Mo; J Suen; M Sommer; A Arvin
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

View more
  4 in total

1.  Development and evaluation of SYBR Green-I based quantitative PCR assays for herpes simplex virus type 1 whole transcriptome analysis.

Authors:  Cathryn E Garvey; Chris L McGowin; Timothy P Foster
Journal:  J Virol Methods       Date:  2014-03-04       Impact factor: 2.014

2.  HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms.

Authors:  Ravi-Kumar Kadeppagari; Rebecca L Sanchez; Timothy P Foster
Journal:  Virus Res       Date:  2012-05-23       Impact factor: 3.303

3.  Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.

Authors:  Maria Dulfary Sanchez; Augusto C Ochoa; Timothy P Foster
Journal:  Antiviral Res       Date:  2016-05-15       Impact factor: 5.970

4.  Herpes Simplex Virus-1 Induced Serotonin-Associated Metabolic Pathways Correlate With Severity of Virus- and Inflammation-Associated Ocular Disease.

Authors:  Diana Marie Battaglia; Maria D Sanchez-Pino; Charles D Nichols; Timothy P Foster
Journal:  Front Microbiol       Date:  2022-03-22       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.